Publications in collaboration with researchers from University of Paris-Sorbonne (28)

2024

  1. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 6, pp. 752-759

  2. A genome-wide association analysis reveals new pathogenic pathways in gout*

    Nature Genetics

2023

  1. Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

    Arthritis and Rheumatology, Vol. 75, Núm. 5, pp. 816-825

  2. Mechanisms and rationale for uricase use in patients with gout

    Nature Reviews Rheumatology, Vol. 19, Núm. 10, pp. 640-649

  3. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 10, pp. 1248-1257

2022

  1. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

    Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658

2021

  1. Serum uric acid and mortality thresholds among men and women in the Irish health system: A cohort study

    European Journal of Internal Medicine, Vol. 84, pp. 46-55

2019

  1. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600

2018

  1. International position paper on the appropriate use of uricosurics with the introduction of lesinurad

    Clinical Rheumatology, Vol. 37, Núm. 12, pp. 3159-3165

2017

  1. 2016 updated EULAR evidence-based recommendations for the management of gout

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 29-42

  2. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 429-438

2016

  1. Computational Lexical Analysis of the Language Commonly Used to Describe Gout

    Arthritis Care and Research, Vol. 68, Núm. 6, pp. 763-768

  2. Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated

    Journal of Rheumatology, Vol. 43, Núm. 1, pp. 150-153

  3. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

    Journal of Allergy and Clinical Immunology, Vol. 138, Núm. 6, pp. 1752-1755

  4. Performance of classification criteria for gout in early and established disease

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 178-182

  5. Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard

    Arthritis Care and Research, Vol. 68, Núm. 12, pp. 1894-1898

  6. The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

    Arthritis and Rheumatology, Vol. 68, Núm. 11, pp. 2795-2805

2015

  1. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 5, pp. 799-805

  2. Serumuric acidandthe riskof cardiovascular and renal disease

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1729-1741

  3. Study for updated gout classification criteria: Identification of features to classify gout

    Arthritis Care and Research, Vol. 67, Núm. 9, pp. 1304-1315